Henglu Biotechnology independently developed the synthetic HMOs route
Shandong Henglu Biotechnology Co., Ltd. has completed two major breakthroughs in the field of HMOs: for the first time in the world, it has achieved ton-level annual production scale-up of biosynthetic LNTⅡ, and for the first time in the world, it has achieved crystals of HMOs. Henglu Biotechnology has gone from enzyme preparation synthesis to whole cell synthesis, organically combining artificial intelligence AI, high-throughput screening and expression to build a "biologically intelligent" synthetic biology R&D platform, called It's called "Biosmart".
For more hot information, insight analysis, research reports, live lectures... Please pay attention to [Hard Technology]
Welcome to look for [Hard Technology] with the blue logo on all major platforms!
is here to see, understand and connect with hard technology! We focus on optoelectronic chips, artificial intelligence, aerospace, new energy, smart cars, biomedicine , science and technology finance and other industries, and rely on the unique scientific and technological intelligence data advantages of the scientific and technological innovation intelligence SaaS service provider Smart Bud. See technology trends with readers, understand the hard technology industry, and connect to the innovative future. "Hard Technology" is produced by the Smart Bud Innovation Research Center.